Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients. - Webb MJ; Neth BJ; Webb LM; Van Gompel JJ; Link MJ; Neff BA; Carlson ML; Driscoll CL; Dornhoffer J; Ruff MW; Anderson KA; Kizilbash SH; et al. (Neuro-oncology advances, 2023)